1 / 22

Morning Report 7/31/07

Morning Report 7/31/07 . 3 rd Degree AV block Jason Haag. Heart Block. 1 st Degree AV Block one-to-one relationship exists between P waves and QRS complexes, but the PR interval is longer than 200 ms. Heart Block. 2 nd Degree Mobitz Type I AV Block (Wenckebach)

carson-silva
Download Presentation

Morning Report 7/31/07

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Morning Report7/31/07 3rd Degree AV block Jason Haag

  2. Heart Block • 1st Degree AV Block • one-to-one relationship exists between P waves and QRS complexes, but the PR interval is longer than 200 ms

  3. Heart Block • 2nd Degree Mobitz Type I AV Block (Wenckebach) • PR interval is prolonging with each P wave to the point when the P wave is no longer conducted

  4. Heart Block • 2nd Degree Mobitz Type II AV Block • PR interval is constant, but occasionally P waves are not followed by the QRS complexes

  5. Heart Block • 3rd Degree Heart Block • More P waves than the QRS complexes exist and no relationship exists between them

  6. 3rd Degree Heart Block • Block can be in AV node or infranodal conduction system • AV node • 2/3 escape rhythms have narrow QRS (junctional) • Fascicular or bundle branches • Wide QRS (subjunctional) • Rate typically in low 40s

  7. Frequency • In the US: 0.02% • Internationally: 0.04%. • Age: Bimodal peak, at infancy given congenital complete AV block and at advance d age due to progressive fibrosis and ischemia

  8. History • Syncope, near-syncope, and lightheadedness • Fatigue, dyspnea, and angina • Asymptomatic • Sudden cardiac death

  9. Physical • Vital Signs (stable vs. unstable, always check HR manually) • Signs of heart failure – JVD, a waves, Pulmonary edema • New murmurs or gallops • Target lesions (Lyme) • Splinter hemm, Osler nodes, etc (endocarditis) • Neuromuscular changes (mytonic/muscular dystrophy)

  10. Etiologies • Idiopathic Progressive Cardiac Conduction Disease • ½ of cases of AV block • Lenegre’s disease • Progressive, fibrotic, sclerodegeneration of the conduction system • Younger individuals, may be hereditary • Lev’s disease • Calcification extending from fibrous structures (aortic/mitral rings) into the conduction system • Older individuals, ? ESRD • Fibrosis NOS • Typically mitral and aortic rings • Mitral  narrow QRS • Aortic  wide QRS

  11. Etiologies (cont.) • Ischemic heart disease • 40% of cases • Either from chronic ischemia or acute MI • Acute MI AV blocks (20% of patients) • 1st degree (8%) • 2nd degree (5%) • 3rd degree (6%) • LBBB/RBBB (10-20%) • AV nodal block (narrow QRS) associated with inferior wall MI • Bundle blocks (wide QRS) associated with anterior wall MI • Drugs • Calcium channel blockers, beta blockers, digoxin, amiodarone, adenosine, quinidine, procainamide

  12. Etiologies (cont.) • Infection • Lyme disease, endocarditis, Rheumatic fever, Chagas disease, myocarditis • Rheumatic disease • Ankylosing spondylitis, Reiter syndrome, relapsing polychondritis, rheumatoid arthritis, scleroderma • Infiltrative disease • Amyloidosis, sarcoidosis, multiple myeloma, hemachromatosis, Wilson’s disease

  13. Etiologies • Hyperthyroidism • Metabolic • Hypoxia, hyperkalemia • Neuromuscular disease • Muscular dystrophy, dermatomyositis

  14. Treatment • Correct underlying problem – if you can • Correct K, stop AV blocking medications, etc. • If unstable • Transcutaneous pacing • If stable • Plan for permanent pacemaker placement

  15. Permanent Pacemaker • Class I - Conditions for which evidence and/or general agreement exists that a given procedure or treatment is beneficial, useful, and effective • Third-degree AV block and advanced second-degree AV block at any anatomic level associated with any one of the following conditions: • Bradycardia with symptoms, heart failure, arrhythmias, pauses greater than 3 seconds, escape rate < 40 bpm

  16. Permanent Pacemaker • Class IIa - Weight of evidence or opinion is in favor of usefulness or efficacy • Asymptomatic third-degree AV block at any anatomic site with average awake ventricular rates of 40 bpm or faster, especially if cardiomegaly or left ventricular (LV) dysfunction is present

  17. References • Gregoratos G, Abrams J, Epstein AE, et al: ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2002 Oct 15; 106(16): 2145-61. • Kojic EM, Hardarson T, Sigfusson N, Sigvaldason H: The prevalence and prognosis of third-degree atrioventricular conduction block: the Reykjavik study. J Intern Med 1999 Jul; 246(1): 81-6. • McEnvoy GK, ed: AHFS Drug Information 2000. Bethesda, Md: American Society of Health-System Pharmacists; 2000: 1187-95. • Ostaner LD, Brandt RL, Kjelsberg MI, et al: Electrocardiographic findings among the adult population of a total natural community. 1965; 31: 888-98. • Rardon DA, Miles WM, Mitrani RD, et al: Electrocardiographic Recognition: Atrioventricular Block and Dissociation. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology From Cell to Bedside, 2nd ed. Philadelphia, Pa: WB Saunders; 1995.

More Related